Howmet Aerospace
HWM NYSE Aerospace & Defense Financials FY2016βFY2025
Howmet Aerospace's revenue rose 11.1% to $8.3 billion in fiscal 2025. Its operating margin was 24.8%, up from 22.0% a year earlier. Free cash flow was $1.4 billion, up 46.5%. It paid out $881 million in dividends and buybacks, 62% of free cash flow. The diluted share count fell 1.0%.
What Howmet Aerospace does
No business description yet.
- Legal name
- HOWMET AEROSPACE INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0000004281-26-000012
0000004281
Revenue and margins
Howmet Aerospace had $8.3B of revenue in fiscal 2025, up 11.1% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.4B in fiscal 2025, 17.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Howmet Aerospace returned $881M to shareholders in fiscal 2025, 62% of free cash flow. The diluted share count fell 1.0%.
Value Howmet Aerospace yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$2.3B and divides by 406.0M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 40.1x Β· peers 23.5x Β· sector 26.0x.
Balance sheet
Cash, debt and the ratios that show how comfortably Howmet Aerospace can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $720M | $791M | $610M | $564M | $742M |
| Debt incl. finance leases | $4.2B | $4.2B | $3.7B | $3.3B | $3.1B |
| Net debt / EBITDA | 3.5x | 2.9x | 2.1x | 1.4x | 1.0x |
| Debt / equity | 1.2x | 1.2x | 0.9x | 0.7x | 0.6x |
| Interest coverage | 2.9x | 4.0x | 5.5x | 8.4x | 11.6x |
| Current ratio | 2.2x | 2.1x | 1.9x | 2.2x | 2.1x |
| Quick ratio | 1.1x | 1.0x | 0.9x | 1.0x | 1.1x |
| Total assets | $10.2B | $10.3B | $10.4B | $10.5B | $11.2B |
| Total liabilities | $6.7B | $6.7B | $6.4B | $6.0B | $5.8B |
| Shareholders' equity | $3.5B | $3.6B | $4.0B | $4.6B | $5.4B |
| Net debt (β = net cash) | $3.5B | $3.4B | $3.1B | $2.8B | $2.3B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$22.9M
2 insiders
Of sales under plans
0%
$0.0M
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 7 / 8 | 8 / 8 | 7 / 8 |
| Accruals ratio | β1.3% | β1.4% | β3.5% |
| Altman Z'' | 2.94 | 3.83 | 4.57 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Howmet Aerospace HWM | $74.7B | 11.1% | 24.8% | 17.3% | 22.4% | 40.1x | 7 | |
| Elbit Systems ESLT | $34.5B | 16.3% | 8.5% | 7.0% | 18.0% | β | 8 | Compare β |
| TransDigm Group TDG | $63.4B | 11.2% | 47.2% | 20.6% | 22.5% | 33.5x | 4 | Compare β |
| Parsons PSN | $5.3B | β5.7% | 6.6% | 6.5% | 9.8% | 23.5x | 7 | Compare β |
| StandardAero SARO | $7.2B | 15.8% | 9.1% | 3.9% | 8.9% | 22.5x | 8 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $12.4B | $13.0B | $6.8B | $7.1B | $5.3B | $5.0B | $5.7B | $6.6B | $7.4B | $8.3B |
| Research and development | $130M | $109M | $41.0M | $28.0M | $17.0M | $17.0M | $32.0M | $36.0M | $33.0M | $37.0M |
| Operating income | $954M | $480M | $775M | $579M | $626M | $748M | $919M | $1.2B | $1.6B | $2.0B |
| Interest expense | $499M | $496M | $377M | $338M | $317M | $259M | $229M | $218M | $195M | $176M |
| Pretax income | $414M | $470M | $428M | $210M | $171M | $324M | $606M | $975M | $1.4B | $1.8B |
| Income tax | $1.5B | $544M | $119M | $84.0M | β$40.0M | $66.0M | $137M | $210M | $228M | $332M |
| Net income | β$941M | β$74.0M | $642M | $470M | $261M | $258M | $469M | $765M | $1.2B | $1.5B |
| Diluted EPS | β$2.31 | β$0.28 | $1.30 | $1.03 | $0.48 | $0.59 | $1.11 | $1.83 | $2.81 | $3.71 |
| Diluted shares | 0.44B | 0.45B | 0.50B | 0.46B | 0.44B | 0.44B | 0.42B | 0.42B | 0.41B | 0.41B |
| Cash flow | ||||||||||
| Cash from operations | $95.0M | β$39.0M | $217M | $461M | $9.0M | $449M | $733M | $901M | $1.3B | $1.9B |
| Capital expenditure | $1.1B | $596M | $768M | $641M | $267M | $199M | $193M | $219M | $321M | $453M |
| Free cash flow | β$1.0B | β$635M | β$551M | β$180M | β$258M | $250M | $540M | $682M | $977M | $1.4B |
| Depreciation and amortization | $1.1B | $551M | $576M | $536M | $338M | $270M | $265M | $272M | $277M | $283M |
| Stock-based compensation | $76.0M | $54.0M | $40.0M | $69.0M | $46.0M | $40.0M | $54.0M | $50.0M | $63.0M | $73.0M |
| Acquisitions | $10.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $5.0M | $0.0M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $1.2B | $73.0M | $430M | $400M | $250M | $500M | $700M |
| Dividends paid | $228M | $162M | $119M | $57.0M | $11.0M | $19.0M | $44.0M | $73.0M | $109M | $181M |
| Dividends and buybacks | $228M | $162M | $119M | $1.2B | $84.0M | $449M | $444M | $323M | $609M | $881M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $1.9B | $2.2B | $2.3B | $1.6B | $1.6B | $720M | $791M | $610M | $564M | $742M |
| Total debt | $8.1B | $6.8B | $6.7B | $7.0B | $5.5B | $4.2B | $4.2B | $3.7B | $3.3B | $3.1B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $5.9B | $6.4B | $6.6B | $5.8B | $3.7B | $2.7B | $3.1B | $3.3B | $3.4B | $3.8B |
| Current liabilities | $2.7B | $2.8B | $3.5B | $4.1B | $1.7B | $1.3B | $1.5B | $1.8B | $1.5B | $1.8B |
| Inventory | $2.3B | $2.5B | $2.5B | $1.6B | $1.5B | $1.4B | $1.6B | $1.8B | $1.8B | $1.8B |
| Property and equipment, net | $5.5B | $5.6B | $5.7B | $2.6B | $2.6B | $2.5B | $2.3B | $2.3B | $2.4B | $2.6B |
| Total assets | $20.0B | $18.7B | $18.7B | $17.6B | $11.4B | $10.2B | $10.3B | $10.4B | $10.5B | $11.2B |
| Total liabilities | $14.9B | $13.8B | $13.1B | $13.0B | $7.9B | $6.7B | $6.7B | $6.4B | $6.0B | $5.8B |
| Shareholders' equity | $5.1B | $4.9B | $5.6B | $4.6B | $3.6B | $3.5B | $3.6B | $4.0B | $4.6B | $5.4B |
| Margins | ||||||||||
| Operating margin | 7.7% | 3.7% | 11.4% | 8.2% | 11.9% | 15.0% | 16.2% | 18.1% | 22.0% | 24.8% |
| EBITDA margin | 16.8% | 8.0% | 19.9% | 15.7% | 18.3% | 20.5% | 20.9% | 22.2% | 25.7% | 28.2% |
| Net margin | β7.6% | β0.6% | 9.5% | 6.6% | 5.0% | 5.2% | 8.3% | 11.5% | 15.6% | 18.3% |
| FCF margin | β8.3% | β4.9% | β8.1% | β2.5% | β4.9% | 5.0% | 9.5% | 10.3% | 13.2% | 17.3% |
| Returns | ||||||||||
| Return on capital | 2.9% | 2.3% | 5.7% | 3.5% | 7.2% | 8.3% | 10.2% | 13.4% | 18.9% | 22.4% |
| Return on capital employed | 3.9% | 2.9% | 5.0% | 4.1% | 5.4% | 8.0% | 10.4% | 13.8% | 18.5% | 22.3% |
| Return on equity | β11.0% | β1.5% | 12.3% | 9.3% | 6.4% | 7.3% | 13.2% | 20.0% | 26.9% | 30.4% |
| Return on assets | β3.3% | β0.4% | 3.4% | 2.6% | 1.8% | 2.4% | 4.6% | 7.4% | 11.0% | 13.9% |
| Growth | ||||||||||
| Revenue growth | β0.2% | 4.6% | β47.7% | 4.7% | β25.9% | β5.5% | 13.9% | 17.3% | 11.9% | 11.1% |
| Net income growth | β | β | β | β26.8% | β44.5% | β1.2% | 81.8% | 63.1% | 51.0% | 30.6% |
| EPS growth | β | β | β | β20.8% | β53.4% | 22.9% | 88.1% | 64.9% | 53.6% | 32.0% |
| FCF growth | β356.2% | β | β | β | β | β | 116.0% | 26.3% | 43.3% | 46.5% |
| Share count change | 4.3% | 3.0% | 11.5% | β8.0% | β5.2% | β0.9% | β3.2% | β1.2% | β1.4% | β1.0% |
| Financial health | ||||||||||
| Net debt / EBITDA | 3.0x | 4.6x | 3.3x | 4.8x | 4.0x | 3.5x | 2.9x | 2.1x | 1.4x | 1.0x |
| Debt / equity | 1.6x | 1.4x | 1.2x | 1.5x | 1.5x | 1.2x | 1.2x | 0.9x | 0.7x | 0.6x |
| Interest coverage | 1.9x | 1.0x | 2.1x | 1.7x | 2.0x | 2.9x | 4.0x | 5.5x | 8.4x | 11.6x |
| Current ratio | 2.1x | 2.3x | 1.9x | 1.4x | 2.2x | 2.2x | 2.1x | 1.9x | 2.2x | 2.1x |
| Quick ratio | 1.3x | 1.4x | 1.2x | 1.0x | 1.3x | 1.1x | 1.0x | 0.9x | 1.0x | 1.1x |
| Capital allocation | ||||||||||
| Capex / revenue | 9.1% | 4.6% | 11.3% | 9.0% | 5.1% | 4.0% | 3.4% | 3.3% | 4.3% | 5.5% |
| Stock comp / revenue | 0.6% | 0.4% | 0.6% | 1.0% | 0.9% | 0.8% | 1.0% | 0.8% | 0.9% | 0.9% |
| Payouts / FCF | β | β | β | β | β | 179.6% | 82.2% | 47.4% | 62.3% | 61.6% |
| Quality scores | ||||||||||
| Piotroski F-score | 4.0 | 4.0 | 3.0 | 4.0 | 5.0 | 6.0 | 6.0 | 7.0 | 8.0 | 7.0 |
| Altman Z'' | 1.5 | 1.6 | 1.7 | 1.3 | 2.1 | 2.2 | 2.6 | 2.9 | 3.8 | 4.6 |
| Accruals ratio | β3.7% | β0.2% | 2.3% | 0.1% | 1.7% | β1.8% | β2.6% | β1.3% | β1.4% | β3.5% |
Source: SEC EDGAR XBRL filings (CIK 0000004281). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.